NFlection Therapeutics, Inc. — Form D/A
NFlection Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2022-06-21. The offering totals $30.0M, of which $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-21
- Form: D/A
- Accession: 0001694227-22-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $20.0M
- Remaining: $10.0M
- Investors: 2
- Date of first sale: 2022-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-448741
Issuer
- Name: NFlection Therapeutics, Inc.
- CIK: 0001694227
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 867 BOYLSTON STREET, 5TH FLOOR, BOSTON, MA, 02116
- Phone: 617-875-4559
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Mark de Souza | Director | Hingham, MA |
| Mark de Souza | Executive Officer | Hingham, MA |
| Corey Goodman | Director | Cambridge, MA |
| Ketan Patel | Director | Cambridge, MA |
| Christopher Powala | Director | Malvern, PA |
| Christopher Powala | Executive Officer | Malvern, PA |
| William Hodder | Director | Boston, MA |
| William Hodder | Executive Officer | Boston, MA |
| Josh Grass | Director | Boston, MA |
| Michael Wootton | Director | Chestnut Hill, MA |
| Michael Wootton | Executive Officer | Chestnut Hill, MA |
Other filings by this issuer (4)
More